基本資料
種類: ETF
費用比率%: 0.75
資產淨值: 36.76
成立日期: 20/11/2023
 
分析
市值分佈:
43.47%
大市值
1.17%
中市值
--
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 01/08/2026 05:21) 總持有投資項目: 16  
0%
 
100%
     10大 (38.76%)
代號 名稱 佔比% 持有日期
LLYEli Lilly & Co11.8730/06/2026
UNHUnitedhealth Group5.4629/07/2026
RHHBYRoche Holding Ltd3.9430/06/2026
AZNAstraZeneca PLC3.4128/07/2026
GILDGilead Sciences2.8728/07/2026
DHRDanaher Corp2.7430/06/2026
VRTXVertex Pharmaceuticals2.7128/07/2026
BMYBristol-Myers Squibb Co2.1428/07/2026
TEVATeva Pharmaceutical Industries Limited1.8830/06/2026
REGNRegeneron Pharmaceuticals1.7429/07/2026
MCKMcKesson Corp1.6530/06/2026
BSXBoston Scientific Corp1.2629/07/2026
ALNYAlnylam Pharmaceuticals1.0029/07/2026
ARWRArrowhead Pharmaceuticals0.7930/06/2026
STOKStoke Therapeutics0.6030/06/2026
KLRAKailera Therapeutics Inc0.5730/06/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.